Back to History

Fields Changed

Registration

Field Before After
Trial Status in_development on_going
Trial End Date December 31, 2020 June 30, 2021
Last Published August 28, 2020 11:53 PM December 17, 2020 05:16 PM
Intervention End Date December 31, 2020 June 30, 2021
Planned Number of Clusters We plan on running a total of 30 sessions, with each session split into 2 matching groups. We plan on running a total of 30 sessions, with each session split into 2 matching groups. [12/17/20] Due to the pandemic, we ran this online using smaller sessions. We have currently run 30 sessions, but plan for an additional 18. With one exception (due to high turnout)
Intervention (Hidden) We propose a laboratory experimental design that allows for varying discount rates. We do this in a deliberately simple manner: (1) subjects never face more than two possible values of δ, (2) they always know the current value of δ, and (3) they know the stochastic process governing changes to δ. Presumably none of these features are replicated in most relevant field settings, but we view this as a necessary first step in exploring the effect of varying δ. All subjects play IRPD games with perfect monitoring using the payoff matrix shown below. Treatments vary the value(s) of δ and whether the value of δ is fixed or possibly changes at the beginning of a new stage game. We use a between subjects design, so all subjects participate in a single treatment, with random assignment of subjects to treatments. Our design contains the following treatments. PD Payoff Matrix C D C 156 5 D 259 110 Baseline (Low and High): The value of δ is fixed at 0.75 throughout a session in Baseline Low and 0.90 in a session of Baseline High. This implies that the expected length of a supergame is only four stage games in Baseline Low versus ten stage games in Baseline High. Combining δ with the payoff matrix, BAD = 0.75 in Baseline Low versus 0.25 in Baseline High. Based on past results, cooperation rates are expected to be low in Baseline Low and substantially higher in Baseline High. Switching: At the beginning of each supergame, an initial continuation probability is randomly selected, either δ = 0.75 or δ = 0.90. Each starting value is equally likely to be selected. At the end of each stage game when δ = 0.75, there is a 20% chance that δ switches to δ = 0.90 for the current stage game. Likewise, if δ = 0.90, there is a 20% chance it switches to δ = 0.75 for the next stage game. It is common knowledge when the value of δ changes. Control (Low and High): The dynamic incentives in Baseline Low and the switching treatments are not the same even in stage games where δ = 0.75 in both cases. In the Baseline Low treatment, the subjects know that this low continuation probability will hold in all future stage games, but in the switching treatments they know that δ might switch. This implies that the expected length of the supergame is less in Baseline Low than in the switching treatments when δ = 0.75. As a result, we do not expect cooperation rates to be the same between Baseline Low and Switching Low even if random switching has no effect beyond altering the dynamic incentives. Similar logic applies to the comparison of Baseline High with Switching High. We therefore added two additional control treatments, Control Low and Control High. We calculate the value of BAD for the initial stage game of Switching with δ = 0.75, accounting for the possibility of switching, and then calibrate the fixed value of δ (rounded to the closest 100th) that gives the same value of BAD. The resulting value of δ = 0.80, yielding BAD = 0.56 as in the switching treatments for stage games where δ = 0.75. Performing the same exercise for Switching with δ = 0.90 yields a fixed value of δ = 0.85 and BAD = 0.40. The value of δ is, therefore, fixed at 0.80 throughout a session in Control Low and 0.85 in a session of Control High. Subjects in all treatments will play ten supergames using a strangers matching, with payment made for one randomly selected supergame. Payoffs will be calibrated to achieve an average payoff of 12 – 15 dollars per hour. Random seeds for the probability of continuation and the probability of switching δ are matched across treatments. This does not generate identical supergame lengths since the continuation probabilities vary, but does imply a similar pattern in terms of when relatively long and short supergames will occur within a session. We plan for five sessions, split into two matching groups, of each treatment. We plan to recruit at least 20 subjects per session. This gives us a minimum of 100 subjects and ten matching groups per treatment. We plan to double the sample for the Switching treatment; this treatment is of greater interest than the others, plus we want the extra data to ease fitting of a structural model. Edit: 3/3/20 After an initial pilot session, we have decided to change the payoff table to the following: C D C 140 10 D 240 100 We have also changed the value of the continuation probabilities to 0.8 and 0.95 for the low and high values respectively. These changes were made for two reasons. 1) The pilot indicated lower than expected cooperation rates. This would make detection of treatment effects quite difficult. The changes lower the value of BAD, making cooperation more likely. 2) We rescaled the payoffs so we could pay in pennies rather than having to convert ECUs to dollars. This was done to reduce subject confusion. Edit 5/19/20 We've had a long delay due to coronavirus, but are ready to start running sessions in a serious way. After finishing piloting, we have made a final tweak to the payoff table to make cooperation a bit easier. C D C 145 30 D 255 100 Edit 8/28/20 We've gone through a long process of running sessions online. We discovered that we could not run sufficiently long sessions online to use the original parameters. We feel that 2 hours is the maximum that we can keep subjects, and that we can run a maximum of 150 stage games in this time period. This is quite a bit less than we could manage in FTF experiments. We have therefore changed the continuation probabilities to 2/3 and 11/20. To generate similar values of SizeBad, the payoff table has been modified as follows. C D C 165 65 D 260 100 We propose a laboratory experimental design that allows for varying discount rates. We do this in a deliberately simple manner: (1) subjects never face more than two possible values of δ, (2) they always know the current value of δ, and (3) they know the stochastic process governing changes to δ. Presumably none of these features are replicated in most relevant field settings, but we view this as a necessary first step in exploring the effect of varying δ. All subjects play IRPD games with perfect monitoring using the payoff matrix shown below. Treatments vary the value(s) of δ and whether the value of δ is fixed or possibly changes at the beginning of a new stage game. We use a between subjects design, so all subjects participate in a single treatment, with random assignment of subjects to treatments. Our design contains the following treatments. PD Payoff Matrix C D C 156 5 D 259 110 Baseline (Low and High): The value of δ is fixed at 0.75 throughout a session in Baseline Low and 0.90 in a session of Baseline High. This implies that the expected length of a supergame is only four stage games in Baseline Low versus ten stage games in Baseline High. Combining δ with the payoff matrix, BAD = 0.75 in Baseline Low versus 0.25 in Baseline High. Based on past results, cooperation rates are expected to be low in Baseline Low and substantially higher in Baseline High. Switching: At the beginning of each supergame, an initial continuation probability is randomly selected, either δ = 0.75 or δ = 0.90. Each starting value is equally likely to be selected. At the end of each stage game when δ = 0.75, there is a 20% chance that δ switches to δ = 0.90 for the current stage game. Likewise, if δ = 0.90, there is a 20% chance it switches to δ = 0.75 for the next stage game. It is common knowledge when the value of δ changes. Control (Low and High): The dynamic incentives in Baseline Low and the switching treatments are not the same even in stage games where δ = 0.75 in both cases. In the Baseline Low treatment, the subjects know that this low continuation probability will hold in all future stage games, but in the switching treatments they know that δ might switch. This implies that the expected length of the supergame is less in Baseline Low than in the switching treatments when δ = 0.75. As a result, we do not expect cooperation rates to be the same between Baseline Low and Switching Low even if random switching has no effect beyond altering the dynamic incentives. Similar logic applies to the comparison of Baseline High with Switching High. We therefore added two additional control treatments, Control Low and Control High. We calculate the value of BAD for the initial stage game of Switching with δ = 0.75, accounting for the possibility of switching, and then calibrate the fixed value of δ (rounded to the closest 100th) that gives the same value of BAD. The resulting value of δ = 0.80, yielding BAD = 0.56 as in the switching treatments for stage games where δ = 0.75. Performing the same exercise for Switching with δ = 0.90 yields a fixed value of δ = 0.85 and BAD = 0.40. The value of δ is, therefore, fixed at 0.80 throughout a session in Control Low and 0.85 in a session of Control High. Subjects in all treatments will play ten supergames using a strangers matching, with payment made for one randomly selected supergame. Payoffs will be calibrated to achieve an average payoff of 12 – 15 dollars per hour. Random seeds for the probability of continuation and the probability of switching δ are matched across treatments. This does not generate identical supergame lengths since the continuation probabilities vary, but does imply a similar pattern in terms of when relatively long and short supergames will occur within a session. We plan for five sessions, split into two matching groups, of each treatment. We plan to recruit at least 20 subjects per session. This gives us a minimum of 100 subjects and ten matching groups per treatment. We plan to double the sample for the Switching treatment; this treatment is of greater interest than the others, plus we want the extra data to ease fitting of a structural model. Edit: 3/3/20 After an initial pilot session, we have decided to change the payoff table to the following: C D C 140 10 D 240 100 We have also changed the value of the continuation probabilities to 0.8 and 0.95 for the low and high values respectively. These changes were made for two reasons. 1) The pilot indicated lower than expected cooperation rates. This would make detection of treatment effects quite difficult. The changes lower the value of BAD, making cooperation more likely. 2) We rescaled the payoffs so we could pay in pennies rather than having to convert ECUs to dollars. This was done to reduce subject confusion. Edit 5/19/20 We've had a long delay due to coronavirus, but are ready to start running sessions in a serious way. After finishing piloting, we have made a final tweak to the payoff table to make cooperation a bit easier. C D C 145 30 D 255 100 Edit 8/28/20 We've gone through a long process of running sessions online. We discovered that we could not run sufficiently long sessions online to use the original parameters. We feel that 2 hours is the maximum that we can keep subjects, and that we can run a maximum of 150 stage games in this time period. This is quite a bit less than we could manage in FTF experiments. We have therefore changed the continuation probabilities to 2/3 and 11/20. To generate similar values of SizeBad, the payoff table has been modified as follows. C D C 165 65 D 260 100 Edit 12/27/20 Based on the number of subjects used thus far and the size of the FSU subject pool, we feel that we can realistically add six more sessions of the existing treatment (one matching group per session) before starting to run short of subjects. We also plan to add a new treatment. In this treatment, the continuation probability switches between super games (there is a 50% chance of each possible continuation probability for each game), but not within super games. This represents an important intermediate case between the fixed discount rate and switching treatments.
Back to top